Consonance Capital Management LP 13D and 13G filings for Kiniksa Pharmaceuticals, Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-11-05 4:55 pm Sale |
2020-10-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA |
Consonance Capital Management LP | 1,252,229 3.990% |
-988,550 (-44.12%) |
Filing |
| 2020-06-16 09:37 am Purchase |
2020-03-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA |
Consonance Capital Management LP | 2,240,779 11.000% |
2,240,779 (New Position) |
Filing |